Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.81 USD | -0.15% | +6.41% | -2.71% |
04-02 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
03-29 | KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 43
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Iwicki
CEO | Chief Executive Officer | 57 | 28/02/15 |
Mary Reumuth
DFI | Director of Finance/CFO | 48 | 31/01/14 |
Todd Bazemore
PSD | President | 53 | 19/11/17 |
Compliance Officer | 51 | 02/04/18 | |
Romulus Brazzell
CTO | Chief Tech/Sci/R&D Officer | 71 | 31/01/13 |
Investor Relations Contact | - | - | |
Darius Kharabi
PRN | Corporate Officer/Principal | 45 | 14/11/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Koven
BRD | Director/Board Member | 66 | 27/09/17 |
Gregory Perry
BRD | Director/Board Member | 63 | 04/03/18 |
Howard Rosen
BRD | Director/Board Member | 66 | 05/01/14 |
Charles Myers
BRD | Director/Board Member | 70 | 14/10/21 |
Mark Blumenkranz
BRD | Director/Board Member | 73 | 14/11/21 |
Mark Iwicki
CEO | Chief Executive Officer | 57 | 28/02/15 |
Marjan Farid
BRD | Director/Board Member | 50 | 30/10/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 2,928 | 0 | 0 | 82.05 % |
Stock B | 1 | 2,816,454 | 2,311,005 ( 82.05 %) | 0 | |
Stock C | 0 | 51,246 | 0 | 0 |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.71% | 19.18M | |
+33.25% | 699B | |
+28.59% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+14.81% | 236B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- KALA Stock
- Company KALA BIO, Inc.